Tag: VASCEPA/VAZKEPA benefits analysis

Amarin Corporation, a leading pharmaceutical company, recently announced groundbreaking research on the clinical impact of VASCEPA/VAZKEPA in patients with diabetes and high cardiovascular risk. This research, supported and funded by Amarin, will be presented...